Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07156396

SleeperOne vs. Conventional Infiltration: Pain Perception in Mandibular Primary Molar Extraction

This clinical trial is being conducted in the Department of Pediatric Dentistry, Faculty of Dentistry, Cairo University. The purpose of the study is to compare the pain perception and comfort of children during tooth extraction when using a computer-controlled local anesthetic device (SleeperOne® 5) versus the conventional syringe infiltration technique.

Children between 3 and 5 years of age who require extraction of a maxillary primary molar will be invited to participate. Before starting, a topical anesthetic gel (benzocaine) will be applied. Then, local anesthesia will be given using either the SleeperOne® device or the traditional syringe, depending on the group assigned.

Pain during injection and extraction will be assessed using both child-friendly rating scales and independent evaluation by the dentist. Patient anxiety, heart rate, and blood pressure will also be recorded.

This study aims to provide evidence on whether computer-controlled anesthesia can reduce children's pain and anxiety compared with the conventional method, leading to a more comfortable dental experience.

The study is a randomized clinical trial and will be conducted in a single visit at the Pediatric Dentistry Outpatient Clinic, Faculty of Dentistry, Cairo University. The results may help improve pain management and patient comfort during dental treatment for children.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

This randomized clinical trial aims to evaluate and compare the pain perception and anxiety levels associated with the use of a computer-controlled local anesthetic delivery system (SleeperOne®) versus conventional local infiltration using a standard syringe in pediatric patients undergoing extraction of mandibular primary molars.

A total of 28 healthy children aged 3 to 5 years, requiring extraction of at least one mandibular primary molar, will be enrolled and randomly assigned into two parallel groups: the intervention group (SleeperOne®) and the control group (conventional syringe). Both groups will receive the same anesthetic solution: 3% Mepivacaine without vasoconstrictor. Topical anesthesia will be applied using 20% benzocaine gel before injection in all participants.

Pain management during dental treatment in children is a major concern in pediatric dentistry. Traditional infiltration anesthesia using a syringe is effective but often associated with pain, anxiety, and fear, which can negatively affect child cooperation. Computer-controlled local anesthetic delivery (CCLAD) systems, such as the SleeperOne® 5, have been developed to minimize these issues by providing a slow and steady flow of anesthesia with improved ergonomics for the operator.

This randomized clinical trial will compare pain perception during maxillary primary molar extraction in children using the SleeperOne® 5 device versus conventional infiltration with a standard dental syringe. The trial will follow a parallel design with two arms: an intervention group receiving local anesthesia via the SleeperOne® 5, and a control group receiving conventional syringe infiltration.

Participants will be children aged 3-5 years who require extraction of a maxillary primary molar. Topical anesthesia with benzocaine will be applied prior to injection in both groups. Local infiltration will then be administered using either the SleeperOne® 5 or a conventional syringe, depending on group allocation.

The primary outcome is pain perception during injection and extraction, measured subjectively using the Wong-Baker Faces Pain Rating Scale (WBFPRS) and objectively using the Sound, Eye, and Motor (SEM) scale by an independent, blinded evaluator. Secondary outcomes include patient anxiety, recorded using the Modified Child Dental Anxiety Scale (MCDAS), and physiological responses (heart rate and blood pressure) measured with a digital monitor.

The study is designed with two parallel groups, with an anticipated sample size of 28 children (14 per group), based on a power calculation. Randomization will be performed using a computer-generated list. Blinding of participants is not possible due to the nature of the interventions, but outcome assessment will be blinded.

The results of this study are expected to provide clinical evidence on whether CCLAD (SleeperOne® 5) offers a significant advantage over conventional infiltration in reducing pain and anxiety during pediatric dental extractions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children Aged between 3 to 5 years.
  • Medically fit children classified as ASA physical status I and II
  • Parents acceptance to participate in the study (informed consent)
  • Children with teeth diagnostically confirmed to require extraction

Exclusion criteria

  • Patients with an allergy to local anesthesia.
  • Uncooperative children
  • Children requiring general anesthesia

Treatment and study plan

SleeperOne®, dental Hitec, France

Device

SleeperOne® is a computerized local anesthetic delivery system used to deliver 3% mepivacaine following application of 20% benzocaine topical gel. It is designed to reduce injection pain and improve comfort during pediatric dental procedures.

Conventional Infiltration

Procedure

Local anesthetic (3% mepivacaine) will be administered using a conventional dental syringe after the application of 20% benzocaine topical anesthetic.

Primary outcomes

  1. Pain during injection

    Time frame: immediately during local anesthetic injection

    Pain during injection will be assessed using the Sound-Eye-Motor (SEM) pain scale, which is a validated observational scale for evaluating pain response in pediatric patients. The SEM scale consists of three components-sound, eye, and motor reaction-each scored from 1 to 4, where a lower score indicates minimal or no pain and a higher score indicates greater discomfort. The total score is interpreted to reflect the child's behavioral reaction to the injection stimulus.

Secondary outcomes

  1. Patient anxiety

    Time frame: During injection and extraction in the same clinical visit

    Patient anxiety will be assessed during the dental anesthesia procedure using the Modified Child Dental Anxiety Scale (MCDAS). The scale provides a subjective measure of the child's level of anxiety, scored from 8 to 40, with higher scores indicating greater anxiety.

  2. Heart rate changes

    Time frame: within 15 minutes after injection

    Heart rate will be monitored using a digital pulse oximeter as an objective measure of patient anxiety. Baseline and intraoperative readings will be compared between groups.

  3. Blood pressure changes

    Time frame: within 15 minutes after injection

    Blood pressure will be recorded using a digital sphygmomanometer to evaluate physiological responses to local anesthesia. Baseline and intraoperative readings will be compared.

  4. Soft tissue injury

    Time frame: Within 24 hours after the procedure.

    Soft tissue injury (lip or cheek biting, trauma due to numbness) will be reported by parents/patients during follow-up. Any incidence will be documented and compared between groups.

Study contacts

Contact information is provided by the study sponsor or research team.

Ameera Alaa ElDin, MSc Candidate in Pediatric Den

CONTACT

[email protected]

01156165654

Sponsors and collaborators

Lead sponsor

Ameera Alaa Eldin Abdalazim Khalifa

Other

Registry information

Official study title

Comparative Evaluation of A Novel Anesthetic Device vs. Conventional Infiltration in Pain Perception Among A Group of Pediatric Patients Undergoing Extraction Of Mandibular Primary Molars: A Randomized Clinical Trial

Acronym: SOTIMAN

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 5, 2025
Registry last updated
Sep 5, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.